 | Todd Foley Sells 19,152 Shares of Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Stock
www.americanbankingnews.com - May 28 at 8:50 PM |
| Todd Foley Sells 25,594 Shares of Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Stock
www.americanbankingnews.com - May 26 at 11:04 PM |
| Insider Selling: Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Director Sells 44,421 Shares of Stock
www.americanbankingnews.com - May 26 at 10:32 PM |
 | Rhythm Pharmaceuticals to Present Virtually at Upcoming Investor Conference in June
finance.yahoo.com - May 26 at 12:53 PM |
| Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Short Interest Down 16.3% in May
www.americanbankingnews.com - May 19 at 1:12 PM |
| Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Director Todd Foley Sells 1,837 Shares
www.americanbankingnews.com - May 15 at 6:48 PM |
| Short Interest in Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Drops By 12.2%
www.americanbankingnews.com - May 13 at 9:36 PM |
| Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 13 at 2:39 AM |
| Insider Selling: Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Director Sells 6,633 Shares of Stock
www.americanbankingnews.com - May 12 at 6:20 PM |
| Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Director Sells $450,632.70 in Stock
www.americanbankingnews.com - May 12 at 5:46 PM |
|
 | Sales of Cardiac Rhythm Management Market to Decelerate in 2020 as COVID-19 Pandemic Takes its Toll on Global Market
www.marketwatch.com - May 12 at 2:24 AM |
| -$0.84 EPS Expected for Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) This Quarter
www.americanbankingnews.com - May 9 at 6:25 AM |
| Todd Foley Sells 1,626 Shares of Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Stock
www.americanbankingnews.com - May 7 at 7:10 PM |
| Rhythm Pharmaceuticals (NASDAQ:RYTM) Issues Quarterly Earnings Results, Beats Expectations By $0.04 EPS
www.americanbankingnews.com - May 5 at 8:46 AM |
| Rhythm Pharmaceuticals to Present Virtually at 2020 BofA Securities Health Care Conference
finance.yahoo.com - May 5 at 8:33 AM |
| Stifel Nicolaus Reaffirms "Buy" Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM)
www.americanbankingnews.com - May 5 at 7:09 AM |
| Needham & Company LLC Reiterates Buy Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM)
www.americanbankingnews.com - May 4 at 5:35 PM |
 | Rhythm Pharmaceuticals EPS beats by $0.02
seekingalpha.com - May 4 at 5:31 PM |
| Rhythm Pharmaceuticals Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 4 at 5:31 PM |
| We're Not Very Worried About Rhythm Pharmaceuticals's (NASDAQ:RYTM) Cash Burn Rate
finance.yahoo.com - April 21 at 1:39 PM |
 | Meet the Apple of Our Eye: Raghu Ram Shares First Pics of Son Rhythm
www.msn.com - April 21 at 8:38 AM |
| Rhythm Pharmaceuticals to Present Virtually at Needham & Co. 19th Annual Healthcare Conference
finance.yahoo.com - April 7 at 5:18 PM |
 | Worldwide Cardiac Monitoring & Cardiac Rhythm Management Devices Market (2019 to 2023) - Forecast and Analysis - ResearchAndMarkets.com
www.businesswire.com - April 2 at 5:04 PM |
| Cardiac Rhythm Management Market Opportunities And Forecast Assessment, 2025
www.marketwatch.com - April 1 at 3:43 PM |
| Rhythm Pharma completes U.S. setmelanotide application
seekingalpha.com - March 30 at 5:59 PM |
| Rhythm Pharmaceuticals Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Setmelanotide in POMC and LEPR Deficiency Obesities
finance.yahoo.com - March 30 at 8:15 AM |
| Rhythm Pharmaceuticals Provides Updates on Leadership Transition and Business Operations
finance.yahoo.com - March 30 at 8:15 AM |
| Cardiac Rhythm Management Devices Market Key Vendors, Topographical Regions, and Industry Segmentation 2026
www.marketwatch.com - March 26 at 6:57 AM |
| Cardiac Rhythm Management Devices Market To Grow At 6.96% CAGR Between 2018 - 2026 analysis by Credence Research
www.marketwatch.com - March 25 at 8:38 AM |
| T.I. announces Netflix's Rhythm & Flow will be back for season 2
www.msn.com - March 24 at 6:59 PM |
|
| Cardiac Monitoring and Cardiac Rhythm Market By Manufacturers, Regions, Type, Application, Forecast 2020-2026
www.marketwatch.com - March 24 at 8:59 AM |
| Cardiac Rhythm Management Devices Market Worldwide Growth, Segmentation, Industry Growth, Trends Forecast to 2026
www.marketwatch.com - March 23 at 9:04 AM |
| Cardiac Monitoring and Cardiac Rhythm Management Market 2020 Global Analysis, Opportunities And Forecast To 2025
www.marketwatch.com - March 19 at 7:28 AM |
| Insights into the Worldwide Cardiac Rhythm Management Market to 2025 - ResearchAndMarkets.com
www.businesswire.com - March 18 at 8:23 AM |
| Rhythm Pharmaceuticals Receives Orphan Drug Designation from U.S. FDA for Setmelanotide for the Treatment of Alström Syndrome
finance.yahoo.com - March 18 at 8:23 AM |
| Cardiac Monitoring and Cardiac Rhythm Market Incredible Possibilities, Growth with Industry Study, Detailed Analysis and Forecast to 2026
www.marketwatch.com - March 11 at 8:15 AM |
| Rhythm Pharmaceuticals EPS beats by $0.10
seekingalpha.com - March 2 at 9:24 AM |
| Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - March 2 at 9:24 AM |
| Rhythm Pharmaceuticals to Present at Cowen & Co. 40th Annual Health Care Conference
finance.yahoo.com - February 25 at 12:49 PM |
| Cardiac Rhythm Management Market Research Report 2019-2025: By Product, Application, Manufacturer, Sales and Segmentation
www.marketwatch.com - January 18 at 12:33 PM |
| Rhythm Pharmaceuticals stock falls on news CEO is leaving
finance.yahoo.com - January 7 at 4:41 PM |
| BRIEF-Rhythm Pharma Says Keith Gottesdiener To Step Down As CEO
www.msn.com - January 7 at 2:25 AM |
| Rhythm Pharma CEO to step down
seekingalpha.com - January 6 at 9:24 PM |
| Rhythm Pharmaceuticals Announces Leadership Transition
finance.yahoo.com - January 6 at 4:23 PM |
| Hedge Funds Are Dumping Rhythm Pharmaceuticals, Inc. (RYTM)
finance.yahoo.com - December 17 at 8:32 PM |
| Rhythm Pharma (+4%) completes enrollment in setmelanotide obesity study
seekingalpha.com - December 5 at 1:46 PM |
| Rhythm Pharmaceuticals Completes Enrollment of Pivotal Cohort in Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
finance.yahoo.com - December 5 at 8:46 AM |
| Rhythm Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - November 22 at 11:18 AM |
 | Rhythm Pharmaceuticals to Present at Stifel 2019 Healthcare Conference
www.globenewswire.com - November 13 at 8:02 AM |
| Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
finance.yahoo.com - November 4 at 7:26 PM |
